Beauty Farm Medical and Health Industry Inc. (2373) reported an on-market repurchase of 50,000 shares on October 21, 2025. The total transaction amounted to approximately HK$1,565,530, at an average price of around HK$31.31 per share.

According to the announcement, the company has repurchased a total of 260,000 shares between October 15, 2025, and the date of the announcement, with an aggregate consideration of about HK$8,423,710. The board cited the current trading price as not reflecting the intrinsic value of the shares or the company’s business prospects, and reaffirmed its confidence in the long-term value of the enterprise.

The repurchase was conducted under a general mandate approved at the company’s annual general meeting on June 27, 2025, allowing the repurchase of up to 23,579,556 shares. The announcement also advises shareholders and potential investors that any future repurchases remain subject to market conditions and the discretion of the directors, and cautions them to exercise care when dealing in the company’s securities.